Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New initiative will help health care providers navigate the process of submitting expanded access requests.
ASCO and Friends of Cancer Research proposed new eligibility guidelines in 2017.
Eighty percent of medications that receive accelerated approval don’t extend overall survival.
Women make up half of the HIV population, but the virus affects them differently than men.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
Researchers believe their greater understanding of leukemia stem cells will lead to more treatment options for people with the blood cancer.
Can data from more than 1 million Americans accelerate research and medical breakthroughs that benefit everyone?
Find out about all the known risks, benefits, rights and responsibilities.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.